Overview

Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

Status:
Unknown status
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Safety and Efficacy of Everolimus in adult de novo liver transplant recipients.
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera di Padova
Treatments:
Everolimus
Sirolimus
Tacrolimus